Clinical research studies are designed to answer specific questions about the safety or effectiveness of drugs, vaccines, other therapies, or new ways of using existing medications. Studies are important for medical research advances. Current treatments for diseases and conditions are only available because of study volunteers.
Learn more about clinical studies at: www.nimh.nih.gov/health/trials/index.html
Participation in this study could last up to 39 weeks, or almost 10 months. The study is divided into three periods:
After a short screening period, participants who choose to take part in the ACCORD study will take an investigational medication (AXS-05, not placebo) for up to 9 weeks. If there is a treatment response (their restlessness, aggression or irritability gets better), they can go into the next part of the study where they have an equal chance (50/50) of taking the investigational medication or a placebo for up to 26 weeks.
Refer a friend
Do you know someone living with dementia from Alzheimer’s who is restless, aggressive, or irritable? Do you know a caregiver of someone with Alzheimer’s who is having a hard time managing their care? They may be eligible to participate in the ACCORD study. Consider sharing information with them about how they can learn more.
See if You Pre-Qualify Now
Complete the following questionnaire to see if someone you know or are caring for is able to pre-qualify for the ACCORD study and get connected with a research site near you.